Table 1

Patients under steroid treatment: reasons for prescription
Condition N (%) References
COPD/asthma/lung fibrosis 30 (18.3) [48,49,52,57-59,68,99,101,118,121,123,128,137,146,153,180-183,185,187,188,192-196]
Leukemia/lymphoma 13 (7.9) [9,17,23,25,37,47,56,98,111,126,162,186]
SLE 9 (5.5) [41,64,66,86,151,176,197,198]
Rheumatoid arthtritis 4 (2.4) [83,103,199,200]
IBD 6 (3.6) [59,147,148,164,177,201]
Sarcoidosis 2 (1.2) [65,132]
Cancer 8 (4.8) [30,54,93,97,112,160,169,202]
Organ/bone marrow transplant 25 (15.2) [21,25,29,31,39,48,51,54,60,70,71,74,76,81,87,88,90,92,94,142,145,150,184]
Glomerulonephritis/CRI 6 (3.6) [16,18,20,129,130,154]
“Idiopatic” eosinophilia 3 (1.8) [7]
Multiple myeloma/myelodisplasia 6 (3.6) [72,185,203-206]
Aspecific symptoms 2 (1.2) [85,166]
Other clinical conditions 46 (28) [17,22,34,36,54,59,66,84,89,100,102,110,113,124,125,127,133-135,140,155,159,171-174,207-213]
HIV-related opportunistic infections/IRIS 4 (2.4) [24,26,36,105]

Buonfrate et al.

Buonfrate et al. BMC Infectious Diseases 2013 13:78   doi:10.1186/1471-2334-13-78

Open Data